rs5030977

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006030.4(CACNA2D2):​c.1260+22G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0844 in 1,613,318 control chromosomes in the GnomAD database, including 6,375 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.065 ( 430 hom., cov: 33)
Exomes 𝑓: 0.086 ( 5945 hom. )

Consequence

CACNA2D2
NM_006030.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.208

Publications

8 publications found
Variant links:
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
CACNA2D2 Gene-Disease associations (from GenCC):
  • cerebellar atrophy with seizures and variable developmental delay
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 3-50379070-C-T is Benign according to our data. Variant chr3-50379070-C-T is described in ClinVar as Benign. ClinVar VariationId is 1253361.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.092 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA2D2NM_006030.4 linkc.1260+22G>A intron_variant Intron 12 of 37 ENST00000424201.7 NP_006021.2 Q9NY47-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA2D2ENST00000424201.7 linkc.1260+22G>A intron_variant Intron 12 of 37 1 NM_006030.4 ENSP00000390329.2 Q9NY47-2
CACNA2D2ENST00000423994.6 linkc.1260+22G>A intron_variant Intron 12 of 38 5 ENSP00000407393.2 C9JVC9
CACNA2D2ENST00000266039.7 linkc.1260+22G>A intron_variant Intron 12 of 37 1 ENSP00000266039.3 Q9NY47-3
CACNA2D2ENST00000360963.7 linkc.1053+22G>A intron_variant Intron 12 of 37 1 ENSP00000354228.3 Q9NY47-4

Frequencies

GnomAD3 genomes
AF:
0.0653
AC:
9943
AN:
152170
Hom.:
431
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0162
Gnomad AMI
AF:
0.157
Gnomad AMR
AF:
0.0639
Gnomad ASJ
AF:
0.120
Gnomad EAS
AF:
0.000384
Gnomad SAS
AF:
0.0275
Gnomad FIN
AF:
0.0954
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0940
Gnomad OTH
AF:
0.0841
GnomAD2 exomes
AF:
0.0722
AC:
18094
AN:
250722
AF XY:
0.0740
show subpopulations
Gnomad AFR exome
AF:
0.0145
Gnomad AMR exome
AF:
0.0449
Gnomad ASJ exome
AF:
0.112
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0992
Gnomad NFE exome
AF:
0.102
Gnomad OTH exome
AF:
0.0833
GnomAD4 exome
AF:
0.0864
AC:
126175
AN:
1461030
Hom.:
5945
Cov.:
32
AF XY:
0.0852
AC XY:
61956
AN XY:
726844
show subpopulations
African (AFR)
AF:
0.0125
AC:
419
AN:
33470
American (AMR)
AF:
0.0469
AC:
2098
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.117
AC:
3046
AN:
26128
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39698
South Asian (SAS)
AF:
0.0334
AC:
2880
AN:
86242
European-Finnish (FIN)
AF:
0.0990
AC:
5267
AN:
53224
Middle Eastern (MID)
AF:
0.0749
AC:
432
AN:
5768
European-Non Finnish (NFE)
AF:
0.0965
AC:
107239
AN:
1111418
Other (OTH)
AF:
0.0794
AC:
4791
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
6717
13433
20150
26866
33583
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3760
7520
11280
15040
18800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0653
AC:
9937
AN:
152288
Hom.:
430
Cov.:
33
AF XY:
0.0640
AC XY:
4768
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.0162
AC:
673
AN:
41560
American (AMR)
AF:
0.0637
AC:
975
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.120
AC:
417
AN:
3470
East Asian (EAS)
AF:
0.000385
AC:
2
AN:
5190
South Asian (SAS)
AF:
0.0275
AC:
133
AN:
4832
European-Finnish (FIN)
AF:
0.0954
AC:
1012
AN:
10608
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.0940
AC:
6390
AN:
68004
Other (OTH)
AF:
0.0828
AC:
175
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
479
958
1438
1917
2396
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0914
Hom.:
323
Bravo
AF:
0.0614
Asia WGS
AF:
0.0160
AC:
58
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 10, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
8.7
DANN
Benign
0.73
PhyloP100
-0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5030977; hg19: chr3-50416501; API